Jane Street
KURA icon

Jane Street’s Kura Oncology KURA Stock Holding History

Jane Street’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Sell
14,900
-11,700
-44% -$110K ﹤0.01% 10281
2026
Q1 		$216K Sell
26,600
-9,300
-26% -$79.9K ﹤0.01% 9969
2025
Q4 		$373K Buy
35,900
+24,600
+218% +$258K ﹤0.01% 8358
2025
Q3 		$100K Buy
+11,300
New +$80.5K ﹤0.01% 10133
2024
Q2 		– Sell
-19,300
Closed -$412K – 9828
2024
Q1 		$412K Buy
+19,300
New +$375K ﹤0.01% 7038
2022
Q1 		– Sell
-13,000
Closed -$182K – 10692
2021
Q4 		$182K Buy
+13,000
New +$211K ﹤0.01% 8882

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Jane Street's KURA Position: Q2 2026 in Review

Jane Street reduced its Kura Oncology (KURA) stake by 89% in Q2 2026, selling an estimated $5.56M and leaving 74,383 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #6962.

Jane Street first reported a position in KURA in Q2 2019 and has held it in 24 quarters since. The position peaked at $5.39M in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Jane Street held 74,383 shares of Kura Oncology worth $816K as of Q2 2026.
  • Jane Street sold 588,967 Kura Oncology shares in Q2 2026, an estimated $5.56M.
  • Kura Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6962 holding.
  • Jane Street first reported a position in Kura Oncology in Q2 2019 and has held it in 24 quarters since.
  • Jane Street's Kura Oncology position peaked at $5.39M in Q1 2026.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.